Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.

[1]  L. Boniforti.  Quantitative Mass Spectrometry in Life Science II , 1980 .

[2]  D. L. Herald,et al.  Isolation and structure of the powerful cell growth inhibitor cephalostatin 1 , 1988 .

[3]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[4]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[5]  J. Dame,et al.  The Plasmodium falciparum Translationally Controlled Tumor Protein Homolog and Its Reaction with the Antimalarial Drug Artemisinin* , 1998, The Journal of Biological Chemistry.

[6]  M. Boyd,et al.  Cytotoxic geranyl stilbenes from Macaranga schweinfurthii. , 1998, Journal of natural products.

[7]  M. K. Harper,et al.  Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata. , 2002, Journal of natural products.

[8]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[9]  Richard D. Smith,et al.  Selective incorporation of isotopically labeled amino acids for identification of intact proteins on a proteome-wide level. , 2002, Journal of mass spectrometry : JMS.

[10]  M. Mann,et al.  Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.

[11]  Anna E Speers,et al.  Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[12]  Benedikt M Kessler,et al.  Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. , 2003, Angewandte Chemie.

[13]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[14]  F. Kaye,et al.  Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells , 2003, Cancer Chemotherapy and Pharmacology.

[15]  J. Geng,et al.  Andrographolide Attenuates Inflammation by Inhibition of NF-κB Activation through Covalent Modification of Reduced Cysteine 62 of p501 , 2004, The Journal of Immunology.

[16]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[17]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[18]  Jeffrey W. Smith,et al.  Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.

[19]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[20]  Guanghui Wang,et al.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of Proteome Research.

[21]  B. Cravatt,et al.  Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.

[22]  L. Zieske.  A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. , 2006, Journal of experimental botany.

[23]  Siyuan Zhang,et al.  Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. , 2006, Biochemical pharmacology.

[24]  Mark D'Ascenzo,et al.  8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease , 2007, Proteomics.

[25]  J. Foley.  Selective Killing , 2007, Science's STKE.

[26]  L. Costa-Lotufo,et al.  Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  A. Tanaka.  [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[28]  David Brown,et al.  Unfinished business: target-based drug discovery. , 2007, Drug discovery today.

[29]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[30]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[31]  J. Geng,et al.  Andrographolide inhibits NF-κB activation and attenuates neointimal hyperplasia in arterial restenosis , 2007, Cell Research.

[32]  Guo-Dong Lu,et al.  Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation , 2008, Molecular Cancer Therapeutics.

[33]  Matthew Bogyo,et al.  Application of activity-based probes to the study of enzymes involved in cancer progression. , 2008, Current opinion in genetics & development.

[34]  F. Boisvert,et al.  Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes , 2008, The Journal of cell biology.

[35]  S. Sieber,et al.  Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. , 2008, Journal of the American Chemical Society.

[36]  M. Bogyo,et al.  Activity-based probes as a tool for functional proteomic analysis of proteases , 2008, Expert review of proteomics.

[37]  B. Mao,et al.  [Andrographolide drop-pill in treatment of acute upper respiratory tract infection with external wind-heat syndrome: a multicenter and randomized controlled trial]. , 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[38]  M. Stevens,et al.  Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis , 2008, British journal of pharmacology.

[39]  W. Wong,et al.  A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-kb Pathway , 2022 .

[40]  G. Superti-Furga,et al.  Target profiling of small molecules by chemical proteomics. , 2009, Nature chemical biology.

[41]  Carolyn R Bertozzi,et al.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.

[42]  Steven A Carr,et al.  Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[43]  Erin E. Carlson,et al.  Natural products as chemical probes. , 2010, ACS chemical biology.

[44]  C. Ong,et al.  Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. , 2010, Biochemical pharmacology.

[45]  M. Wenk,et al.  Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities. , 2010, Journal of the American Chemical Society.

[46]  Benjamin F. Cravatt,et al.  Activity-based protein profiling for biochemical pathway discovery in cancer , 2010, Nature Reviews Cancer.

[47]  Thomas Böttcher,et al.  Natural products and their biological targets: proteomic and metabolomic labeling strategies. , 2010, Angewandte Chemie.

[48]  Matthias Mann,et al.  Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics , 2011, Nature Protocols.

[49]  H. Overkleeft,et al.  Bioorthogonal chemistry: applications in activity-based protein profiling. , 2011, Accounts of chemical research.

[50]  T. Golub,et al.  Selective killing of cancer cells with a small molecule targeting stress response to ROS , 2011, Nature.

[51]  Pengyu Yang,et al.  Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes. , 2011, Chemistry, an Asian journal.

[52]  J. Kaiser.  Will an aspirin a day keep cancer away? , 2012, Science.

[53]  M. Uttamchandani,et al.  Comparative proteomic profiling of mammalian cell lysates using phosphopeptide microarrays. , 2012, Chemical communications.

[54]  Shao Q Yao,et al.  Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. , 2012, Journal of the American Chemical Society.

[55]  Bernhard Kuster,et al.  Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present , 2012, Analytical and Bioanalytical Chemistry.

[56]  Yaxue Zhao,et al.  Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. , 2012, Nature chemical biology.

[57]  Karunakaran A Kalesh,et al.  Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. , 2012, Biochemical pharmacology.

[58]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[59]  B. Kemp,et al.  The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase , 2012, Science.

[60]  Steven J Brown,et al.  Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes. , 2012, Journal of the American Chemical Society.

[61]  S. Sieber,et al.  Electrophilic natural products and their biological targets. , 2012, Natural product reports.

[62]  Martial Rey,et al.  Probing protein interactions with hydrogen/deuterium exchange and mass spectrometry-a review. , 2012, Analytica chimica acta.

[63]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[64]  Yuguo Zheng,et al.  Target identification of biologically active small molecules via in situ methods. , 2013, Current opinion in chemical biology.

[65]  Brett Larsen,et al.  Label-free quantitative proteomics trends for protein-protein interactions. , 2013, Journal of proteomics.

[66]  Matthew R. Pratt,et al.  An alkyne-aspirin chemical reporter for the detection of aspirin-dependent protein modification in living cells. , 2013, Journal of the American Chemical Society.

[67]  Amber L. Couzens,et al.  The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.

[68]  Herbert Waldmann,et al.  Target identification for small bioactive molecules: finding the needle in the haystack. , 2013, Angewandte Chemie.

[69]  Y. Ikeda,et al.  Non-Specific Protein Modifications by a Phytochemical Induce Heat Shock Response for Self-Defense , 2013, PloS one.

[70]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[71]  H. Waldmann,et al.  A natural product inspired tetrahydropyran collection yields mitosis modulators that synergistically target CSE1L and tubulin. , 2013, Angewandte Chemie.

[72]  D. Audenaert,et al.  Target Identification of Biologically Active Small Molecules , 2013 .

[73]  Jigang Wang,et al.  Development of a novel method for quantification of autophagic protein degradation by AHA labeling , 2014, Autophagy.

[74]  Han-Ming Shen,et al.  A Quantitative Chemical Proteomics Approach to Profile the Specific Cellular Targets of Andrographolide, a Promising Anticancer Agent That Suppresses Tumor Metastasis* , 2014, Molecular & Cellular Proteomics.

[75]  Z. Gong,et al.  Dramatic Improvement of Proteomic Analysis of Zebrafish Liver Tumor by Effective Protein Extraction with Sodium Deoxycholate and Heat Denaturation , 2015, International journal of analytical chemistry.

[76]  Bin Liu,et al.  Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum , 2015, Nature Communications.

[77]  A. Adibekian,et al.  Proteome-Wide Profiling of Targets of Cysteine reactive Small Molecules by Using Ethynyl Benziodoxolone Reagents. , 2015, Angewandte Chemie.

[78]  Gang Li,et al.  Affinity purification in target identification: the specificity challenge , 2015, Archives of Pharmacal Research.

[79]  W. Wong,et al.  Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-κB p50. , 2015, Journal of natural products.

[80]  Herbert Waldmann,et al.  Hide and seek: Identification and confirmation of small molecule protein targets. , 2015, Bioorganic & medicinal chemistry letters.

[81]  Karunakaran A Kalesh,et al.  Target profiling of zerumbone using a novel cell-permeable clickable probe and quantitative chemical proteomics. , 2015, Chemical communications.

[82]  Jigang Wang,et al.  Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP) , 2015, Scientific Reports.